Suicide and Microglia: Recent Findings and Future Perspectives Based on Human Studies.

PET imaging depression iMG cells microglia neuroinflammation postmortem suicide tryptophan-kynurenine pathway

Journal

Frontiers in cellular neuroscience
ISSN: 1662-5102
Titre abrégé: Front Cell Neurosci
Pays: Switzerland
ID NLM: 101477935

Informations de publication

Date de publication:
2019
Historique:
received: 10 08 2018
accepted: 22 01 2019
entrez: 1 3 2019
pubmed: 1 3 2019
medline: 1 3 2019
Statut: epublish

Résumé

Suicide is one of the most disastrous outcomes for psychiatric disorders. Recent advances in biological psychiatry have suggested a positive relationship between some specific brain abnormalities and specific symptoms in psychiatric disorders whose organic bases were previously completely unknown. Microglia, immune cells in the brain, are regarded to play crucial roles in brain inflammation by releasing inflammatory mediators and are suggested to contribute to various psychiatric disorders such as depression and schizophrenia. Recently, activated microglia have been suggested to be one of the possible contributing cells to suicide and suicidal behaviors

Identifiants

pubmed: 30814929
doi: 10.3389/fncel.2019.00031
pmc: PMC6381042
doi:

Types de publication

Journal Article

Langues

eng

Pagination

31

Références

Nat Neurosci. 2011 Mar;14(3):285-93
pubmed: 21346746
PLoS One. 2012;7(7):e40461
pubmed: 22808165
FEBS J. 2012 Apr;279(8):1375-85
pubmed: 22404766
J Affect Disord. 2018 Nov;240:88-98
pubmed: 30059939
J Neural Transm (Vienna). 2012 Feb;119(2):245-51
pubmed: 22139324
Curr Med Chem. 2013;20(3):331-44
pubmed: 23157624
Nat Rev Drug Discov. 2010 Dec;9(12):971-88
pubmed: 21119734
Neuropathol Appl Neurobiol. 2014 Oct;40(6):697-713
pubmed: 24016036
Neurosci Biobehav Rev. 2018 Jul;90:16-25
pubmed: 29608993
Brain. 2000 Nov;123 ( Pt 11):2321-37
pubmed: 11050032
Transl Psychiatry. 2016 Nov 8;6(11):e946
pubmed: 27824355
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Apr 5;42:146-53
pubmed: 23178230
Curr Psychiatry Rep. 2017 Jun;19(6):31
pubmed: 28470485
Exp Neurol. 2007 Jul;206(1):33-42
pubmed: 17481608
Cereb Cortex. 2012 Jun;22(6):1442-54
pubmed: 21878486
J Neurosci Res. 2010 Aug 15;88(11):2431-40
pubmed: 20623536
Biol Psychiatry. 2018 Jan 1;83(1):61-69
pubmed: 28939116
Psychol Med. 2001 Oct;31(7):1193-202
pubmed: 11681545
Brain Behav Immun. 2011 Aug;25(6):1272-8
pubmed: 21605657
World Psychiatry. 2014 Jun;13(2):153-60
pubmed: 24890068
Brain. 1999 Apr;122 ( Pt 4):593-624
pubmed: 10219775
FASEB J. 2016 Nov;30(11):3853-3859
pubmed: 27511944
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):42-8
pubmed: 17716796
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):702-21
pubmed: 21185346
Brain Behav Immun. 2016 Jul;55:17-24
pubmed: 26551431
Brain Behav Immun. 2015 Jan;43:110-7
pubmed: 25124710
Am J Pathol. 2011 Oct;179(4):2016-27
pubmed: 21872563
J Psychiatr Res. 2015 Jul-Aug;66-67:118-26
pubmed: 26009299
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Apr 5;42:115-21
pubmed: 22192886
Trends Neurosci. 2008 Jul;31(7):361-70
pubmed: 18538868
Physiol Behav. 2019 Feb 1;199:386-394
pubmed: 30529512
Mol Neurobiol. 2018 Feb;55(2):1524-1536
pubmed: 28181189
Lancet. 2009 Apr 18;373(9672):1372-81
pubmed: 19376453
JAMA Psychiatry. 2013 Jan;70(1):49-58
pubmed: 23404112
Psychoneuroendocrinology. 2011 Apr;36(3):426-36
pubmed: 21041030
Eur Arch Psychiatry Clin Neurosci. 2017 Aug;267(5):403-415
pubmed: 28229240
Neuropsychopharmacology. 2013 Apr;38(5):743-52
pubmed: 23299933
Free Radic Biol Med. 2018 Jan;114:110-121
pubmed: 28882786
Schizophr Res. 2007 May;92(1-3):108-15
pubmed: 17363222
Glia. 2016 Nov;64(11):1801-40
pubmed: 27634048
J Affect Disord. 2018 Jan 1;225:569-576
pubmed: 28886497
J Neurochem. 2008 Jul;106(2):815-25
pubmed: 18429930
Biol Psychiatry. 2008 Nov 1;64(9):820-2
pubmed: 18534557
Psychol Med. 1993 Nov;23(4):1023-32
pubmed: 8134505
J Neuroinflammation. 2011 Aug 10;8:94
pubmed: 21831269
Lancet Psychiatry. 2018 Apr;5(4):339-347
pubmed: 29496589
Acta Pharmacol Sin. 2019 Mar;40(3):351-357
pubmed: 29921889
J Nucl Med. 2009 Nov;50(11):1801-7
pubmed: 19837763
Front Integr Neurosci. 2013 Jul 15;7:53
pubmed: 23874274
Psychiatry Res. 2015 Jun 30;227(2-3):206-12
pubmed: 25865484
Prog Neurobiol. 2005 Jun;76(2):77-98
pubmed: 16081203
Psychopharmacology (Berl). 2008 Jun;198(3):431-45
pubmed: 18452034
Br J Psychiatry. 2000 Nov;177:447-51
pubmed: 11059999
J Psychiatry Neurosci. 2018 Nov 01;43(6):376-385
pubmed: 30371993
Nature. 2011 Apr 21;472(7343):319-24
pubmed: 21389984
Front Cell Neurosci. 2018 Nov 20;12:433
pubmed: 30524242
Physiol Rev. 2011 Apr;91(2):461-553
pubmed: 21527731
Front Psychiatry. 2013 Oct 21;4:139
pubmed: 24155727
BMC Psychiatry. 2017 Jun 29;17(1):234
pubmed: 28662694
Mini Rev Med Chem. 2011 Jun;11(7):565-74
pubmed: 21699487
PLoS One. 2016 Dec 16;11(12):e0165267
pubmed: 27984586
J Neuropathol Exp Neurol. 2014 Sep;73(9):880-90
pubmed: 25101704
JAMA. 2005 Oct 26;294(16):2064-74
pubmed: 16249421
Mol Psychiatry. 2014 Jun;19(6):699-709
pubmed: 24342992
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Oct 3;70:8-16
pubmed: 27117820
J Neurol Neurosurg Psychiatry. 2006 Jan;77(1):120-2
pubmed: 16361611
Am J Psychiatry. 2016 Jan;173(1):44-52
pubmed: 26472628
Front Hum Neurosci. 2013 Feb 04;7:13
pubmed: 23443737
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Oct 1;34(7):1306-16
pubmed: 20654672
J Neuroinflammation. 2014 Jan 21;11:12
pubmed: 24447857
Psychiatry Clin Neurosci. 2009 Jun;63(3):257-65
pubmed: 19579286
Eur Arch Psychiatry Clin Neurosci. 2015 Jun;265(4):321-9
pubmed: 25409655
Front Cell Neurosci. 2015 May 27;9:184
pubmed: 26074765
Neuroscience. 2007 May 25;146(3):1388-99
pubmed: 17433555
Soc Psychiatry Psychiatr Epidemiol. 2005 Jun;40(6):446-53
pubmed: 16003594
J Biol Chem. 2012 Mar 30;287(14):10977-89
pubmed: 22303002
Psychoneuroendocrinology. 2016 Sep;71:189-96
pubmed: 27318828
Sci Rep. 2017 Sep 19;7(1):11882
pubmed: 28928366
World J Biol Psychiatry. 2016 Dec;17(8):564-586
pubmed: 26223957
Curr Top Behav Neurosci. 2017;31:269-284
pubmed: 27221623
Neuropharmacology. 2017 Jan;112(Pt B):324-330
pubmed: 26820800
Brain Behav Immun. 2014 Nov;42:50-9
pubmed: 24858659
Glia. 2012 Nov;60(11):1747-60
pubmed: 22847985
Transl Psychiatry. 2017 Apr 11;7(4):e1092
pubmed: 28398339
Mini Rev Med Chem. 2011 Jun;11(7):555-64
pubmed: 21699486
Acta Neuropathol. 2006 Sep;112(3):305-16
pubmed: 16783554
Front Immunol. 2017 Jan 09;7:676
pubmed: 28119691
J Neurochem. 2012 Mar;120(6):948-63
pubmed: 22182318
J Psychiatr Res. 2012 Jan;46(1):57-63
pubmed: 21906753
Brain Behav Immun. 2010 Oct;24(7):1058-68
pubmed: 20153418
JAMA Psychiatry. 2015 Mar;72(3):268-75
pubmed: 25629589
Int J Neuropsychopharmacol. 2010 Aug;13(7):943-50
pubmed: 20350336
J Psychiatry Neurosci. 2016 Oct;41(6):386-394
pubmed: 27070351
Schizophr Res. 2016 Dec;178(1-3):35-43
pubmed: 27614570
Sci Rep. 2013;3:1685
pubmed: 23595250
Transl Psychiatry. 2016 Aug 02;6(8):e865
pubmed: 27483383
Curr Top Med Chem. 2018;18(19):1704-1715
pubmed: 30430940
J Affect Disord. 2018 Apr 15;231:74-82
pubmed: 29454180
J Psychiatr Res. 2008 Jan;42(2):151-7
pubmed: 17174336
Arch Gen Psychiatry. 2003 Sep;60(9):878-88
pubmed: 12963669
Front Neurol. 2018 Apr 12;9:239
pubmed: 29706930
Sci Rep. 2014 May 14;4:4957
pubmed: 24825127
Schizophr Res. 2011 Jul;129(2-3):172-82
pubmed: 21497059
Neuroscience. 2015 May 21;294:60-8
pubmed: 25711936

Auteurs

Hisaomi Suzuki (H)

National Hospital Organization Shimofusa Psychiatric Medical Center, Chiba, Japan.

Masahiro Ohgidani (M)

Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Nobuki Kuwano (N)

Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Fabrice Chrétien (F)

Neuropathology Department, Sainte-Anne Hospital, Paris, France.
Human Histopathology and Animal Models Laboratory, Institute Pasteur, Paris, France.

Geoffroy Lorin de la Grandmaison (G)

Department of Pathology and Forensic Medicine, Raymond Poincaré University Hospital, Garches, France.

Mitsumoto Onaya (M)

National Hospital Organization Shimofusa Psychiatric Medical Center, Chiba, Japan.

Itaru Tominaga (I)

National Hospital Organization Shimofusa Psychiatric Medical Center, Chiba, Japan.

Daiki Setoyama (D)

Department of Clinical Chemistry and Laboratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Dongchon Kang (D)

Department of Clinical Chemistry and Laboratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Masaru Mimura (M)

Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.

Shigenobu Kanba (S)

Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Takahiro A Kato (TA)

Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Classifications MeSH